Patents Assigned to NEOLYS DIAGNOSTICS
  • Publication number: 20180238859
    Abstract: A predictive method of cellular, tissue and clinical radiosensitivity, which is based on the determination and cross-checking of a plurality of cellular and enzymatic parameters and criteria applied to a tumor response. The predictive method characterizes the sensitivity of a tumor in response to a DNA-breaking radiotherapy treatment.
    Type: Application
    Filed: August 16, 2016
    Publication date: August 23, 2018
    Applicants: NEOLYS DIAGNOSTICS, INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, CENTRE LEON BERARD, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE CLAUDE BERNARD LYON 1
    Inventors: Nicolas FORAY, Larry BODGI, Sandrine PEREIRA